Perimeter Medical Imaging: Our Journey to the OTCQX Market Beginning February 27, 2025: A Heartfelt and Insightful Look into the Future of AI-Powered Medical Diagnostics

Perimeter Medical Imaging AI’s OTCQX Listing: A Game Changer for the Company and the Medical Imaging Industry

On February 25, 2025, Perimeter Medical Imaging AI, Inc. (TSXV: PINK) announced that its common shares will commence trading on the OTCQX® Best Market under the symbol “PYNKF,” effective from the open of business on February 27, 2025. This listing is a significant milestone for the commercial-stage medical technology company, as many of its shareholders are based in the United States, and the U.S. is the primary target market for Perimeter’s current S-Series OCT (Optical Coherence Tomography) system and its upcoming AI-enabled B-Series product.

Impact on Perimeter Medical Imaging AI

Perimeter’s Chief Executive Officer, Adrian Mendes, expressed his excitement about this development, stating, “We are thrilled to join the OTCQX Best Market, which will provide our U.S. investors with a more liquid trading market for their Perimeter shares. This listing is an important step as we continue to execute on our growth strategy and bring our innovative OCT technology to more hospitals and clinics in the U.S. and around the world.”

This listing on the OTCQX Best Market will provide Perimeter with increased visibility and access to a broader investor base in the U.S. It also signifies that the company has met the highest financial standards and has demonstrated compliance with applicable securities laws. As a result, Perimeter’s shares may become more attractive to institutional investors and individual investors in the U.S., potentially leading to increased trading volume and share price stability.

Impact on the Medical Imaging Industry

Perimeter’s listing on the OTCQX Best Market is not only a significant achievement for the company but also a testament to the growing importance of artificial intelligence (AI) and OCT technology in the medical imaging industry. OCT is a non-invasive imaging technology that provides real-time, cross-sectional images of tissue, allowing for the early detection and diagnosis of various medical conditions. The integration of AI into OCT systems can significantly enhance image analysis, leading to improved clinical outcomes and reduced healthcare costs.

Perimeter’s AI-enabled B-Series OCT system is expected to revolutionize the medical imaging industry by providing real-time, automated detection and measurement of tissue structures and lesions, enabling faster and more accurate diagnoses. The system’s advanced AI algorithms can analyze vast amounts of data in real-time, helping medical professionals make informed decisions more efficiently and effectively. This technology has the potential to transform the way medical conditions are diagnosed and treated, ultimately improving patient care and outcomes.

Conclusion

Perimeter Medical Imaging AI’s listing on the OTCQX Best Market represents a major step forward for the company as it continues to expand its presence in the U.S. market and bring its innovative OCT technology to more hospitals and clinics. This development is not only a significant achievement for Perimeter but also a testament to the growing importance of AI and OCT technology in the medical imaging industry. The integration of AI into OCT systems, such as Perimeter’s AI-enabled B-Series product, has the potential to transform the way medical conditions are diagnosed and treated, ultimately leading to improved patient care and outcomes. As the medical imaging industry continues to evolve, Perimeter is well-positioned to lead the way with its advanced technology and commitment to innovation.

  • Perimeter Medical Imaging AI to begin trading on OTCQX Best Market under symbol “PYNKF”
  • Many of Perimeter’s shareholders are based in the U.S., and the U.S. is the primary target market for the company’s current S-Series OCT system and upcoming AI-enabled B-Series product
  • Listing on OTCQX Best Market provides increased visibility and access to a broader investor base in the U.S.
  • Perimeter’s AI-enabled B-Series OCT system has the potential to revolutionize the medical imaging industry by providing real-time, automated detection and measurement of tissue structures and lesions
  • Integration of AI into OCT systems, such as Perimeter’s B-Series product, can significantly enhance image analysis and improve clinical outcomes

In summary, Perimeter Medical Imaging AI’s listing on the OTCQX Best Market is a significant milestone for the company and the medical imaging industry. This development will provide Perimeter with increased visibility and access to a broader investor base in the U.S., ultimately leading to potential growth and increased share price stability. Moreover, the integration of AI into OCT systems, such as Perimeter’s AI-enabled B-Series product, has the potential to revolutionize the medical imaging industry by providing faster and more accurate diagnoses, ultimately leading to improved patient care and outcomes.

As a potential investor or medical professional, this development highlights the growing importance of Perimeter Medical Imaging AI and its innovative technology in the medical imaging industry. Stay tuned for further updates on Perimeter’s growth and the impact of its AI-enabled OCT systems on the medical imaging landscape.

Leave a Reply